X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
0
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211636
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211636
https://www.moneycontrol.com/news/business/lupin-gets-usfda-nod-to-market-generic-anthelmintic-tablets-5392451.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211117
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208979
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210011
https://health.economictimes.indiatimes.com/news/pharma/strides-jv-gets-usfda-nod-for-tapeworm-infection-treatment-drug/67039543
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210434
https://www.pharmacompass.com/pdf/news/list-of-off-patent-off-exclusivity-drugs-without-an-approved-generic-1499253832.pdf
https://www.pharmacompass.com/pdf/news/anvisa-suspends-lot-of-the-vermiculite-benzol-1491476976.pdf
https://www.pharmacompass.com/pdf/news/anvisa-prohibits-brainfarmas-anti-helmintic-drug-albendazole-1476881573.pdf
http://portal.anvisa.gov.br/noticias?p_p_id=101_INSTANCE_FXrpx9qY7FbU&p_p_col_id=column-2&p_p_col_pos=1&p_p_col_count=2&_101_INSTANCE_FXrpx9qY7FbU_groupId=219201&_101_INSTANCE_FXrpx9qY7FbU_urlTitle=lote-de-vermifugo-da-prati-donaduzzi-e-suspenso&_101_INSTANCE_FXrpx9qY7FbU_struts_action=%2Fasset_publisher%2Fview_content&_101_INSTANCE_FXrpx9qY7FbU_assetEntryId=2908739&_101_INSTANCE_FXrpx9qY7FbU_type=content
http://twofourinsight.com/usfda-denies-citizen-petition-amedra-albenza-generic-entry-horizon/
http://portal.anvisa.gov.br/wps/content/anvisa+portal/anvisa/sala+de+imprensa/menu+-+noticias+anos/201616/lote+de+antiparasitario+e+suspenso
http://portal.anvisa.gov.br/wps/content/anvisa+portal/anvisa/sala+de+imprensa/menu+-+noticias+anos/2015/albendazol+400mg+da+empresa+cimed+e+interditado
http://portal.anvisa.gov.br/wps/content/anvisa+portal/anvisa/sala+de+imprensa/menu+-+noticias+anos/2015/generico+albendazol+400mg+da+prati+donaduzzi++tem+lote+interditado
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/207844Orig1s000ltr.pdf
http://www.fiercepharmamanufacturing.com/story/attix-pharmaceuticals-recalls-hundreds-apis-us/2015-04-30
http://www.forbes.com/sites/peterubel/2015/03/31/millions-to-be-made-on-generic-drugs/
Market Place
Share 
